Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check14 days agoChange DetectedThe page has updated its dates and specific numerical values, indicating a shift in the timeline and possibly in the context of the content. Notably, the removal of 'Estimated' suggests a move towards more definitive information.SummaryDifference0.4%
- Check22 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a clinical trial for selpercatinib (LOXO-292) and the addition of new identifiers and collaborators related to the study. The revision number has also been updated.SummaryDifference27%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 28, 2025.SummaryDifference0.2%
- Check36 days agoChange DetectedThe page has been updated to include information on Medullary Thyroid Cancer while removing references to Papillary Thyroid Carcinoma.SummaryDifference0.1%
- Check65 days agoChange DetectedThe webpage has updated its date references, removing older dates from January 2025 and adding new dates in February 2025.SummaryDifference0.3%
Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.